Low-Dose Immunotherapy Plus Triple Metronomic Chemotherapy for Head and Neck Cancer

Affiliations

¹ Dun-Chang Mo, MD, Jian-Feng Huang, MD, and Peng-Hui Luo, MD, Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Comment

Dun-Chang Mo et al. J Clin Oncol. 2023.

. 2023 Mar 20;41(9):1790.

doi: 10.1200/JCO.22.02398. Epub 2023 Jan 20.

¹ Dun-Chang Mo, MD, Jian-Feng Huang, MD, and Peng-Hui Luo, MD, Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

No abstract available

Comment in

Reply to D.-C. Mo et al.
Patil VM, Noronha V, Prabhash K, Bhattacharjee A. Patil VM, et al. J Clin Oncol. 2023 Mar 20;41(9):1791. doi: 10.1200/JCO.22.02741. Epub 2023 Jan 20. J Clin Oncol. 2023. PMID: 36669137 No abstract available.

Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study.
Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K. Patil VM, et al. J Clin Oncol. 2023 Jan 10;41(2):222-232. doi: 10.1200/JCO.22.01015. Epub 2022 Oct 20. J Clin Oncol. 2023. PMID: 36265101 Clinical Trial.